CollaGenex Pharmaceuticals, Inc.

Periostat maker files patent infringement claim against IVAX, CorePharma

Published in Pharma Law Weekly, November 2nd, 2004

CollaGenex Pharmaceuticals, Inc., (CGPI) announced that it has filed a complaint for patent infringement against IVAX Pharmaceuticals, Inc., and CorePharma, LLC, (defendants) in the United States District Court for the Eastern District of New York.

CollaGenex alleges the defendants' submissions of abbreviated new drug applications (ANDAs) covering their 20 mg tablets of doxycycline hyclate infringe United States patent RE 34,656, of which CollaGenex is the exclusive licensee. CollaGenex is seeking an injunction preventing the defendants from introducing 20 mg tablets of doxycycline hyclate into the market in the United States.

CollaGenex markets its...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2004-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry